Persistent URL of this record https://hdl.handle.net/1887/116109
In Collections
This item can be found in the following collections:
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
- All authors
- Smolen, J.S.; Landewe, R.; Bijlsma, J.; Burmester, G.; Chatzidionysiou, K.; Dougados, M.; Nam, J.; Ramiro, S.; Voshaar, M.; Vollenhoven, R. van; Aletaha, D.; Aringer, M.; Boers, M.; Buckley, C.D.; Buttgereit, F.; Bykerk, V.; Cardiel, M.; Combe, B.; Cutolo, M.; Eijk-Hustings, Y. van; Emery, P.; Finckh, A.; Gabay, C.; Gomez-Reino, J.; Gossec, L.; Gottenberg, J.E.; Hazes, J.M.W.; Huizinga, T.; Jani, M.; Karateev, D.; Kouloumas, M.; Kvien, T.; Li, Z.G.; Mariette, X.; McInnes, I.; Mysler, E.; Nash, P.; Pavelka, K.; Poor, G.; Richez, C.; Riel, P. van; Rubbert-Roth, A.; Saag, K.; Silva, J. da; Stamm, T.; Takeuchi, T.; Westhovens, R.; Wit, M. de; Heijde, D. van der
- Date
- 2017-06-30
- Journal
- Annals of the Rheumatic Diseases
- Volume
- 76
- Issue
- 6
- Pages
- 960 - 977